What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Vall d'Hebron discovers a new antibody in patients with scleroderma that will help in the diagnosis of this disease Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer. Activities Vall d'Hebron Talks by VHIR 'Pathophysiology and treatment of sensorymotor diseases' Speaker: Dr. Arnau Hervera, main researcher Clinical Neuroimmunology, Vall Hebron Institut de Recerca (VHIR) Abstract: Sensorimotor diseases including spinal cord injuries and multiple sclerosis, are diseases currently without a cure associated with severe chronic neurological disabilit News The HITIHE project concludes with a meeting of all project members in Antwerp As part of the initiative, WikiTropica, a tool that provides health professionals with up-to-date information on infectious and tropical diseases, has been launched. Activities Vall d'Hebron Talks by VHIR 'Project Application for Animal Experimentation' Speaker: Dr. Sergio Salazar. Sergio obtained his Bachelor's degree in Veterinary Science from the University of Córdoba in 2006 and has worked as a designated veterinarian, project manager, and animal facility manager during his fifteen-year career in animal experimentation. Activities Vall d'Hebron Talks by VHIR 'The KDM6A/B inhibition affects viability of SMARCB1 deficient tumors through the disruption of autophagy and angiogenesis in pediatric cancer' Speaker: Octavio Alfredo Romero Ferraro, principal investigator cancer epigenetics and Biology Program - Josep Carreras Research Institute (IJC) In Pediatric cancer, the traditional cytotoxic therapeutic approaches are always a compromise between treatment efficacy and the risk of News A single dose of attenuated vaccines could protect multiple sclerosis patients before starting immunosuppressive therapy This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment. Activities Defensa de Tesi 'Dinàmica del microbioma i del viroma després del trasplantament de pulmó i el seu impacte en el pronòstic dels receptors a llarg termini' Doctoranda: Victoria Ruiz de Miguel, grup de Pnuemologia (VHIR) Ddirectors de la tesi són: Dra. Susana Gómez Ollés i Dr. Antonio Román Broto Activities Workshop CONCILE 'Monitorització de la resposta cel·lular T davant del CMV en el trasplantament. Del laboratori a la pràctica clínica' Ponents Dr. Oriol Bestard, Servei de Nefrologia i Trasplantament renal, Hospital Universitari Vall d’Hebron, Barcelona Dr. Mario Fernández-Ruiz, Servei de Malalties Infeccioses, Hospital 12 d'octubre, Madrid Dr. Oscar Len, Servei de Malalties Infeccioses. Hos Activities Vall d'Hebron Talks 'Chemsex Què cal saber?' Ponent: Dr. Jorge Nestor García Pérez, metge especialista en Medicina Interna de l'Hospital Universitari Vall d'Hebron La seva activitat assistencial es desenvolupa al servei de Malalties Infeccioses de l'Hospital Universitari Vall d'Hebron, concretament a l'àrea de VIH i infeccions de Activities XXI Congrés Nacional de l'Associació Espanyola d'Infermeria en Otorinolaringologia i Cap i Coll https://congresos.aeeorl.es/ News We launch the campaign 'Research and enjoy, join!' to attract and engage talent The aim is to make visible the attractiveness of VHIR as a place to work highlighting the unique opportunities it offers for biomedical research professionals at national and international level. News Vall d'Hebron promotes the national network ReALLNet to promote research in relapsed acute lymphoblastic leukaemia The initiative, coordinated by Dr. Pablo Velasco and Dr. Jose Luis Fuster, aims to bring innovation closer to patients and promote research projects in this disease. News Two VHIR projects selected for the CaixaImpulse Health Innovation programme This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training. Activities Jornada BIB Alumni La Comunitat BIB Alumni neix amb la voluntat d’esdevenir un punt de trobada al voltant de la bioinformàtica on alumnes, exalumnes, grups de recerca, empreses i socis del BIB poden col·laborar, relacionar-se i crear noves oportunitats Activities Vall d'Hebron Talks 'Model de cures centrat en el pacient i la família i participació familiar: coneixements i pràctiques de les infermeres' Ponent: Laia Ventura Expósito, infermera referent neurologia pediàtrica de l'Hospital Universitari Vall d'Hebron i investigadora principal del Grup de Recerca Multidisciplinari d'Infermeria del Vall d'Hebron Institut de Recerca (VHIR) Presentació d'una part dels resultats extrets del pr Activities II Curso de impacto de las nuevas tecnologías en el control de la diabetes Más información https://aula.vallhebron.com/aula/?go=info_cursos&curso=554 Aula Vall d'Hebron Activities Vall d'Hebron Talks 'Cervell inflamat: com el sistema immunològic pot portar a patir símptomes psiquiàtrics' Ponent: Dra. Gara Arteaga Henríquez, psiquiatre, del Servei de Psiquiatria de l'Hospital Universitaru Vall d'Hebron. CV: La Dra. Gara Arteaga Henríquez (Psiquiatre) col·labora, des de fa més de 8 anys, en diversos projectes internacionals en el camp de la Immunopsiquiatria ( Activities Vall d'Hebron Talks by VHIR 'Genome Editing in Biomedicine in 2023 and beyond' Speaker: Dr. Lluís Montoliu (CNB-CSIC). Lluis Montoliu is a CSIC Research Scientist at the National Centre for Biotechnology and at the Spanish Research Initiative on Rare Diseases, in Madrid, Spain after working in Heidelberg and Barcelona. He is the Director of the Spanish node of the Activities Ultrasons, de la natura a la medicina Del 1 de setembre al 15 d'octubre, el Museu de Ciències Naturals de Granollers acull l'exposicio Ultrasons, de la natura a la medicina, impulsada pel Servei de Radiologia de Vall d'Hebron a través de la nova línia de recerca anomenada FUSMED, que estudia els efecte News RBDCOV project members meet at Vall d'Hebron to advance the development of the BIMERVAX vaccine RBDCOV aims to test the HIPRA vaccine against COVID-19 in children (including adolescents) and immunocompromised people. Pagination First page « Previous page ‹ … Page 22 Page 23 Current page 24 Page 25 Page 26 … Next page › Last page »
